nodes	percent_of_prediction	percent_of_DWPC	metapath
Pindolol—Ocular discomfort—Methotrexate—esophageal cancer	0.0262	0.0514	CcSEcCtD
Pindolol—Peripheral coldness—Capecitabine—esophageal cancer	0.0168	0.0329	CcSEcCtD
Pindolol—Keratitis—Capecitabine—esophageal cancer	0.0123	0.0242	CcSEcCtD
Pindolol—Pain—Carboplatin—esophageal cancer	0.0113	0.0221	CcSEcCtD
Pindolol—Wheezing—Cisplatin—esophageal cancer	0.0105	0.0207	CcSEcCtD
Pindolol—Psoriasis—Methotrexate—esophageal cancer	0.00946	0.0186	CcSEcCtD
Pindolol—Cardiac failure congestive—Cisplatin—esophageal cancer	0.00867	0.017	CcSEcCtD
Pindolol—Orthostatic hypotension—Cisplatin—esophageal cancer	0.00718	0.0141	CcSEcCtD
Pindolol—Cramp muscle—Cisplatin—esophageal cancer	0.00708	0.0139	CcSEcCtD
Pindolol—Sleep disorder—Capecitabine—esophageal cancer	0.0067	0.0132	CcSEcCtD
Pindolol—Abdominal discomfort—Cisplatin—esophageal cancer	0.00652	0.0128	CcSEcCtD
Pindolol—Hot flush—Capecitabine—esophageal cancer	0.0062	0.0122	CcSEcCtD
Pindolol—Menopausal symptoms—Capecitabine—esophageal cancer	0.00615	0.0121	CcSEcCtD
Pindolol—Cardiac failure—Capecitabine—esophageal cancer	0.00594	0.0117	CcSEcCtD
Pindolol—Lethargy—Capecitabine—esophageal cancer	0.00592	0.0116	CcSEcCtD
Pindolol—Conjunctivitis—Cisplatin—esophageal cancer	0.00589	0.0116	CcSEcCtD
Pindolol—Bradycardia—Cisplatin—esophageal cancer	0.00554	0.0109	CcSEcCtD
Pindolol—Nadolol—ABCB1—esophageal cancer	0.00541	0.27	CrCbGaD
Pindolol—Orthostatic hypotension—Capecitabine—esophageal cancer	0.0053	0.0104	CcSEcCtD
Pindolol—Visual impairment—Cisplatin—esophageal cancer	0.00524	0.0103	CcSEcCtD
Pindolol—Tinnitus—Cisplatin—esophageal cancer	0.00507	0.00996	CcSEcCtD
Pindolol—Cardiac disorder—Cisplatin—esophageal cancer	0.00505	0.00992	CcSEcCtD
Pindolol—Bronchospasm—Capecitabine—esophageal cancer	0.00493	0.00968	CcSEcCtD
Pindolol—Mediastinal disorder—Cisplatin—esophageal cancer	0.0049	0.00963	CcSEcCtD
Pindolol—Abdominal discomfort—Capecitabine—esophageal cancer	0.0048	0.00943	CcSEcCtD
Pindolol—Atenolol—ABCB1—esophageal cancer	0.00472	0.236	CrCbGaD
Pindolol—Flatulence—Cisplatin—esophageal cancer	0.00467	0.00917	CcSEcCtD
Pindolol—Weight increased—Capecitabine—esophageal cancer	0.00456	0.00896	CcSEcCtD
Pindolol—Visual disturbance—Methotrexate—esophageal cancer	0.00456	0.00894	CcSEcCtD
Pindolol—Muscle spasms—Cisplatin—esophageal cancer	0.00455	0.00894	CcSEcCtD
Pindolol—Depression—Capecitabine—esophageal cancer	0.00446	0.00875	CcSEcCtD
Pindolol—Tremor—Cisplatin—esophageal cancer	0.00444	0.00871	CcSEcCtD
Pindolol—Lethargy—Methotrexate—esophageal cancer	0.00441	0.00865	CcSEcCtD
Pindolol—Acebutolol—ABCB1—esophageal cancer	0.00436	0.218	CrCbGaD
Pindolol—Conjunctivitis—Capecitabine—esophageal cancer	0.00434	0.00853	CcSEcCtD
Pindolol—Bradycardia—Capecitabine—esophageal cancer	0.00408	0.00802	CcSEcCtD
Pindolol—Myalgia—Cisplatin—esophageal cancer	0.00403	0.00792	CcSEcCtD
Pindolol—Anxiety—Cisplatin—esophageal cancer	0.00402	0.00789	CcSEcCtD
Pindolol—Oedema—Cisplatin—esophageal cancer	0.00387	0.00759	CcSEcCtD
Pindolol—Visual impairment—Capecitabine—esophageal cancer	0.00387	0.00759	CcSEcCtD
Pindolol—Nervous system disorder—Cisplatin—esophageal cancer	0.00379	0.00744	CcSEcCtD
Pindolol—Tachycardia—Cisplatin—esophageal cancer	0.00377	0.00741	CcSEcCtD
Pindolol—Tinnitus—Capecitabine—esophageal cancer	0.00374	0.00734	CcSEcCtD
Pindolol—Hyperhidrosis—Cisplatin—esophageal cancer	0.00374	0.00734	CcSEcCtD
Pindolol—Cardiac disorder—Capecitabine—esophageal cancer	0.00372	0.00731	CcSEcCtD
Pindolol—Metoprolol—ABCB1—esophageal cancer	0.00368	0.184	CrCbGaD
Pindolol—Angiopathy—Capecitabine—esophageal cancer	0.00364	0.00715	CcSEcCtD
Pindolol—Mediastinal disorder—Capecitabine—esophageal cancer	0.00362	0.0071	CcSEcCtD
Pindolol—Hypotension—Cisplatin—esophageal cancer	0.00361	0.00709	CcSEcCtD
Pindolol—Abdominal discomfort—Methotrexate—esophageal cancer	0.00358	0.00702	CcSEcCtD
Pindolol—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.00352	0.00692	CcSEcCtD
Pindolol—Mental disorder—Capecitabine—esophageal cancer	0.00351	0.0069	CcSEcCtD
Pindolol—Paraesthesia—Cisplatin—esophageal cancer	0.00347	0.00682	CcSEcCtD
Pindolol—Dyspnoea—Cisplatin—esophageal cancer	0.00345	0.00677	CcSEcCtD
Pindolol—Flatulence—Capecitabine—esophageal cancer	0.00344	0.00676	CcSEcCtD
Pindolol—Erectile dysfunction—Methotrexate—esophageal cancer	0.00344	0.00675	CcSEcCtD
Pindolol—Muscle spasms—Capecitabine—esophageal cancer	0.00336	0.00659	CcSEcCtD
Pindolol—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.00334	0.00655	CcSEcCtD
Pindolol—Drowsiness—Methotrexate—esophageal cancer	0.00333	0.00653	CcSEcCtD
Pindolol—Depression—Methotrexate—esophageal cancer	0.00332	0.00651	CcSEcCtD
Pindolol—Pain—Cisplatin—esophageal cancer	0.00331	0.00649	CcSEcCtD
Pindolol—Tremor—Capecitabine—esophageal cancer	0.00327	0.00642	CcSEcCtD
Pindolol—Conjunctivitis—Methotrexate—esophageal cancer	0.00323	0.00635	CcSEcCtD
Pindolol—Sweating—Methotrexate—esophageal cancer	0.00319	0.00626	CcSEcCtD
Pindolol—Feeling abnormal—Cisplatin—esophageal cancer	0.00319	0.00626	CcSEcCtD
Pindolol—Vertigo—Capecitabine—esophageal cancer	0.00314	0.00616	CcSEcCtD
Pindolol—Syncope—Capecitabine—esophageal cancer	0.00313	0.00615	CcSEcCtD
Pindolol—Palpitations—Capecitabine—esophageal cancer	0.00309	0.00606	CcSEcCtD
Pindolol—Loss of consciousness—Capecitabine—esophageal cancer	0.00307	0.00603	CcSEcCtD
Pindolol—Arthralgia—Capecitabine—esophageal cancer	0.00297	0.00584	CcSEcCtD
Pindolol—Chest pain—Capecitabine—esophageal cancer	0.00297	0.00584	CcSEcCtD
Pindolol—Myalgia—Capecitabine—esophageal cancer	0.00297	0.00584	CcSEcCtD
Pindolol—Anxiety—Capecitabine—esophageal cancer	0.00296	0.00582	CcSEcCtD
Pindolol—Dry mouth—Capecitabine—esophageal cancer	0.00291	0.00571	CcSEcCtD
Pindolol—Visual impairment—Methotrexate—esophageal cancer	0.00288	0.00565	CcSEcCtD
Pindolol—Confusional state—Capecitabine—esophageal cancer	0.00287	0.00564	CcSEcCtD
Pindolol—Oedema—Capecitabine—esophageal cancer	0.00285	0.0056	CcSEcCtD
Pindolol—Shock—Capecitabine—esophageal cancer	0.0028	0.00551	CcSEcCtD
Pindolol—Nervous system disorder—Capecitabine—esophageal cancer	0.0028	0.00549	CcSEcCtD
Pindolol—Tinnitus—Methotrexate—esophageal cancer	0.00278	0.00547	CcSEcCtD
Pindolol—Tachycardia—Capecitabine—esophageal cancer	0.00278	0.00546	CcSEcCtD
Pindolol—Asthenia—Cisplatin—esophageal cancer	0.00277	0.00545	CcSEcCtD
Pindolol—Cardiac disorder—Methotrexate—esophageal cancer	0.00277	0.00544	CcSEcCtD
Pindolol—Hyperhidrosis—Capecitabine—esophageal cancer	0.00276	0.00541	CcSEcCtD
Pindolol—Angiopathy—Methotrexate—esophageal cancer	0.00271	0.00532	CcSEcCtD
Pindolol—Mediastinal disorder—Methotrexate—esophageal cancer	0.00269	0.00528	CcSEcCtD
Pindolol—Hypotension—Capecitabine—esophageal cancer	0.00266	0.00523	CcSEcCtD
Pindolol—Diarrhoea—Cisplatin—esophageal cancer	0.00265	0.00519	CcSEcCtD
Pindolol—Mental disorder—Methotrexate—esophageal cancer	0.00262	0.00514	CcSEcCtD
Pindolol—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.0026	0.0051	CcSEcCtD
Pindolol—Insomnia—Capecitabine—esophageal cancer	0.00258	0.00506	CcSEcCtD
Pindolol—Paraesthesia—Capecitabine—esophageal cancer	0.00256	0.00502	CcSEcCtD
Pindolol—Dyspnoea—Capecitabine—esophageal cancer	0.00254	0.00499	CcSEcCtD
Pindolol—Dyspepsia—Capecitabine—esophageal cancer	0.00251	0.00493	CcSEcCtD
Pindolol—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.00246	0.00483	CcSEcCtD
Pindolol—Vomiting—Cisplatin—esophageal cancer	0.00246	0.00483	CcSEcCtD
Pindolol—Fatigue—Capecitabine—esophageal cancer	0.00246	0.00482	CcSEcCtD
Pindolol—Rash—Cisplatin—esophageal cancer	0.00244	0.00479	CcSEcCtD
Pindolol—Pain—Capecitabine—esophageal cancer	0.00244	0.00479	CcSEcCtD
Pindolol—Constipation—Capecitabine—esophageal cancer	0.00244	0.00479	CcSEcCtD
Pindolol—Dermatitis—Cisplatin—esophageal cancer	0.00244	0.00478	CcSEcCtD
Pindolol—Feeling abnormal—Capecitabine—esophageal cancer	0.00235	0.00461	CcSEcCtD
Pindolol—Vertigo—Methotrexate—esophageal cancer	0.00234	0.00459	CcSEcCtD
Pindolol—Gastrointestinal pain—Capecitabine—esophageal cancer	0.00233	0.00458	CcSEcCtD
Pindolol—Nausea—Cisplatin—esophageal cancer	0.0023	0.00451	CcSEcCtD
Pindolol—Abdominal pain—Capecitabine—esophageal cancer	0.00225	0.00442	CcSEcCtD
Pindolol—Arthralgia—Methotrexate—esophageal cancer	0.00221	0.00435	CcSEcCtD
Pindolol—Chest pain—Methotrexate—esophageal cancer	0.00221	0.00435	CcSEcCtD
Pindolol—Myalgia—Methotrexate—esophageal cancer	0.00221	0.00435	CcSEcCtD
Pindolol—Confusional state—Methotrexate—esophageal cancer	0.00214	0.0042	CcSEcCtD
Pindolol—Nervous system disorder—Methotrexate—esophageal cancer	0.00208	0.00409	CcSEcCtD
Pindolol—Hyperhidrosis—Methotrexate—esophageal cancer	0.00205	0.00403	CcSEcCtD
Pindolol—Asthenia—Capecitabine—esophageal cancer	0.00204	0.00402	CcSEcCtD
Pindolol—Pruritus—Capecitabine—esophageal cancer	0.00202	0.00396	CcSEcCtD
Pindolol—Hypotension—Methotrexate—esophageal cancer	0.00198	0.00389	CcSEcCtD
Pindolol—Diarrhoea—Capecitabine—esophageal cancer	0.00195	0.00383	CcSEcCtD
Pindolol—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.00193	0.0038	CcSEcCtD
Pindolol—Insomnia—Methotrexate—esophageal cancer	0.00192	0.00377	CcSEcCtD
Pindolol—Paraesthesia—Methotrexate—esophageal cancer	0.00191	0.00374	CcSEcCtD
Pindolol—Dyspnoea—Methotrexate—esophageal cancer	0.00189	0.00371	CcSEcCtD
Pindolol—Somnolence—Methotrexate—esophageal cancer	0.00189	0.0037	CcSEcCtD
Pindolol—Dizziness—Capecitabine—esophageal cancer	0.00188	0.0037	CcSEcCtD
Pindolol—Dyspepsia—Methotrexate—esophageal cancer	0.00187	0.00367	CcSEcCtD
Pindolol—Propranolol—ABCB1—esophageal cancer	0.00186	0.0927	CrCbGaD
Pindolol—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.00183	0.0036	CcSEcCtD
Pindolol—Fatigue—Methotrexate—esophageal cancer	0.00183	0.00359	CcSEcCtD
Pindolol—Pain—Methotrexate—esophageal cancer	0.00181	0.00356	CcSEcCtD
Pindolol—Vomiting—Capecitabine—esophageal cancer	0.00181	0.00356	CcSEcCtD
Pindolol—Rash—Capecitabine—esophageal cancer	0.0018	0.00353	CcSEcCtD
Pindolol—Dermatitis—Capecitabine—esophageal cancer	0.0018	0.00353	CcSEcCtD
Pindolol—Headache—Capecitabine—esophageal cancer	0.00179	0.00351	CcSEcCtD
Pindolol—Feeling abnormal—Methotrexate—esophageal cancer	0.00175	0.00343	CcSEcCtD
Pindolol—Gastrointestinal pain—Methotrexate—esophageal cancer	0.00173	0.00341	CcSEcCtD
Pindolol—Nausea—Capecitabine—esophageal cancer	0.00169	0.00332	CcSEcCtD
Pindolol—Abdominal pain—Methotrexate—esophageal cancer	0.00168	0.00329	CcSEcCtD
Pindolol—Asthenia—Methotrexate—esophageal cancer	0.00152	0.00299	CcSEcCtD
Pindolol—Pruritus—Methotrexate—esophageal cancer	0.0015	0.00295	CcSEcCtD
Pindolol—Diarrhoea—Methotrexate—esophageal cancer	0.00145	0.00285	CcSEcCtD
Pindolol—Dizziness—Methotrexate—esophageal cancer	0.0014	0.00275	CcSEcCtD
Pindolol—Vomiting—Methotrexate—esophageal cancer	0.00135	0.00265	CcSEcCtD
Pindolol—Rash—Methotrexate—esophageal cancer	0.00134	0.00263	CcSEcCtD
Pindolol—Dermatitis—Methotrexate—esophageal cancer	0.00134	0.00262	CcSEcCtD
Pindolol—Headache—Methotrexate—esophageal cancer	0.00133	0.00261	CcSEcCtD
Pindolol—Nausea—Methotrexate—esophageal cancer	0.00126	0.00247	CcSEcCtD
Pindolol—HTR1B—Signaling Pathways—CSNK1A1—esophageal cancer	0.000564	0.0012	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—ADCYAP1—esophageal cancer	0.00056	0.00119	CbGpPWpGaD
Pindolol—HTR1B—Signaling by GPCR—ANXA1—esophageal cancer	0.000559	0.00119	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—PDE4D—esophageal cancer	0.000559	0.00119	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—ADCYAP1—esophageal cancer	0.000548	0.00116	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—PDE4D—esophageal cancer	0.000546	0.00116	CbGpPWpGaD
Pindolol—HTR1B—Signaling by GPCR—SST—esophageal cancer	0.000544	0.00115	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—GNG7—esophageal cancer	0.000543	0.00115	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—GNG7—esophageal cancer	0.000541	0.00115	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—GNG7—esophageal cancer	0.000531	0.00113	CbGpPWpGaD
Pindolol—HTR1B—Signaling by GPCR—GHRL—esophageal cancer	0.00053	0.00113	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—PFN1—esophageal cancer	0.000528	0.00112	CbGpPWpGaD
Pindolol—ADRB1—GPCR downstream signaling—CXCL2—esophageal cancer	0.000527	0.00112	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—WWOX—esophageal cancer	0.000524	0.00111	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—GNG7—esophageal cancer	0.00052	0.0011	CbGpPWpGaD
Pindolol—ADRB2—GPCR downstream signaling—CXCL2—esophageal cancer	0.000516	0.0011	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—WWOX—esophageal cancer	0.000512	0.00109	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—XIAP—esophageal cancer	0.000507	0.00108	CbGpPWpGaD
Pindolol—HTR1A—GPCR downstream signaling—CXCL2—esophageal cancer	0.000504	0.00107	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—WWOX—esophageal cancer	0.000501	0.00106	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—FKBP1A—esophageal cancer	0.000498	0.00106	CbGpPWpGaD
Pindolol—ADRB1—GPCR downstream signaling—ANXA1—esophageal cancer	0.00049	0.00104	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—FKBP1A—esophageal cancer	0.000487	0.00104	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—WIF1—esophageal cancer	0.000487	0.00103	CbGpPWpGaD
Pindolol—ADRB2—GPCR downstream signaling—ANXA1—esophageal cancer	0.000479	0.00102	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—CTNNA1—esophageal cancer	0.000479	0.00102	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—CXCL2—esophageal cancer	0.000479	0.00102	CbGpPWpGaD
Pindolol—ADRB1—GPCR downstream signaling—SST—esophageal cancer	0.000477	0.00101	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—CXCL2—esophageal cancer	0.000476	0.00101	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—FKBP1A—esophageal cancer	0.000476	0.00101	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—WIF1—esophageal cancer	0.000476	0.00101	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—ELMO1—esophageal cancer	0.000474	0.00101	CbGpPWpGaD
Pindolol—HTR1A—GPCR downstream signaling—ANXA1—esophageal cancer	0.000469	0.000996	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—CXCL2—esophageal cancer	0.000468	0.000995	CbGpPWpGaD
Pindolol—ADRB2—GPCR downstream signaling—SST—esophageal cancer	0.000466	0.000991	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—WIF1—esophageal cancer	0.000466	0.000989	CbGpPWpGaD
Pindolol—ADRB1—GPCR downstream signaling—GHRL—esophageal cancer	0.000465	0.000987	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—AKAP13—esophageal cancer	0.000463	0.000984	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—CXCL2—esophageal cancer	0.000458	0.000973	CbGpPWpGaD
Pindolol—HTR1A—GPCR downstream signaling—SST—esophageal cancer	0.000456	0.000969	CbGpPWpGaD
Pindolol—ADRB2—GPCR downstream signaling—GHRL—esophageal cancer	0.000454	0.000965	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—CSNK1A1—esophageal cancer	0.000449	0.000955	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—PSME2—esophageal cancer	0.000445	0.000946	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—PSME1—esophageal cancer	0.000445	0.000946	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—ANXA1—esophageal cancer	0.000445	0.000945	CbGpPWpGaD
Pindolol—HTR1A—GPCR downstream signaling—GHRL—esophageal cancer	0.000444	0.000944	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—ANXA1—esophageal cancer	0.000443	0.000941	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—CSNK1A1—esophageal cancer	0.000439	0.000934	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—ANXA1—esophageal cancer	0.000435	0.000925	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—SST—esophageal cancer	0.000433	0.00092	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—SST—esophageal cancer	0.000431	0.000915	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—CSNK1A1—esophageal cancer	0.00043	0.000913	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—HIST1H2BM—esophageal cancer	0.000428	0.000908	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—ANXA1—esophageal cancer	0.000426	0.000904	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—PDE4D—esophageal cancer	0.000424	0.0009	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—SST—esophageal cancer	0.000423	0.0009	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—GHRL—esophageal cancer	0.000422	0.000896	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—PFN1—esophageal cancer	0.00042	0.000893	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—GHRL—esophageal cancer	0.00042	0.000892	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—NOTCH3—esophageal cancer	0.00042	0.000892	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—SST—esophageal cancer	0.000414	0.00088	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—FBXW7—esophageal cancer	0.000413	0.000878	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—GHRL—esophageal cancer	0.000413	0.000877	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—PFN1—esophageal cancer	0.000411	0.000873	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—GHRL—esophageal cancer	0.000404	0.000857	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—GNG7—esophageal cancer	0.000403	0.000856	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—PFN1—esophageal cancer	0.000402	0.000854	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—BLVRB—esophageal cancer	0.000394	0.000838	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—SLC52A3—esophageal cancer	0.000394	0.000838	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—XIAP—esophageal cancer	0.000378	0.000802	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—ELMO1—esophageal cancer	0.000377	0.000802	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—NOTCH2—esophageal cancer	0.000377	0.0008	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—ELMO1—esophageal cancer	0.000369	0.000784	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—AKAP13—esophageal cancer	0.000369	0.000784	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—ELMO1—esophageal cancer	0.000361	0.000767	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—AKAP13—esophageal cancer	0.000361	0.000767	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—CTNNA1—esophageal cancer	0.000357	0.000759	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—CXCL2—esophageal cancer	0.000355	0.000754	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—AKAP13—esophageal cancer	0.000353	0.00075	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—HIST1H2BM—esophageal cancer	0.00034	0.000723	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—PDE4D—esophageal cancer	0.000337	0.000717	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—CA1—esophageal cancer	0.000335	0.000713	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—SLC10A2—esophageal cancer	0.000335	0.000713	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—TGFBR2—esophageal cancer	0.000334	0.00071	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—HIST1H2BM—esophageal cancer	0.000333	0.000708	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—PSME1—esophageal cancer	0.000332	0.000705	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—PSME2—esophageal cancer	0.000332	0.000705	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—PDE4D—esophageal cancer	0.00033	0.000701	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—ANXA1—esophageal cancer	0.00033	0.000701	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—HIST1H2BM—esophageal cancer	0.000326	0.000692	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—PDE4D—esophageal cancer	0.000323	0.000686	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—SST—esophageal cancer	0.000321	0.000682	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—GNG7—esophageal cancer	0.000321	0.000682	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—SMAD4—esophageal cancer	0.000316	0.000672	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—GNG7—esophageal cancer	0.000314	0.000667	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—NOTCH3—esophageal cancer	0.000313	0.000665	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—GHRL—esophageal cancer	0.000313	0.000665	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—FBXW7—esophageal cancer	0.000308	0.000654	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—GNG7—esophageal cancer	0.000307	0.000652	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—CA2—esophageal cancer	0.000307	0.000652	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—XIAP—esophageal cancer	0.000301	0.000639	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—XIAP—esophageal cancer	0.000294	0.000625	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—XIAP—esophageal cancer	0.000288	0.000611	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—PLCE1—esophageal cancer	0.000285	0.000606	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—ADH7—esophageal cancer	0.000285	0.000606	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—CTNNA1—esophageal cancer	0.000284	0.000604	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—CXCL2—esophageal cancer	0.000283	0.000601	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—NOTCH2—esophageal cancer	0.000281	0.000596	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—CTNNA1—esophageal cancer	0.000278	0.000591	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—CXCL2—esophageal cancer	0.000277	0.000588	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—CTNNA1—esophageal cancer	0.000272	0.000578	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—CXCL2—esophageal cancer	0.00027	0.000575	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—PSME2—esophageal cancer	0.000264	0.000561	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—PSME1—esophageal cancer	0.000264	0.000561	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—ANXA1—esophageal cancer	0.000263	0.000559	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—HIF1A—esophageal cancer	0.000259	0.00055	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—PSME1—esophageal cancer	0.000258	0.000549	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—PSME2—esophageal cancer	0.000258	0.000549	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—ANXA1—esophageal cancer	0.000257	0.000546	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—SST—esophageal cancer	0.000256	0.000543	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—PSME2—esophageal cancer	0.000253	0.000537	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—PSME1—esophageal cancer	0.000253	0.000537	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—ANXA1—esophageal cancer	0.000251	0.000534	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—SST—esophageal cancer	0.00025	0.000531	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—ADH1B—esophageal cancer	0.00025	0.000531	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—GHRL—esophageal cancer	0.000249	0.000529	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—NOTCH3—esophageal cancer	0.000249	0.000529	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—TGFBR2—esophageal cancer	0.000249	0.000529	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—KDR—esophageal cancer	0.000247	0.000526	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—FBXW7—esophageal cancer	0.000245	0.000521	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—SST—esophageal cancer	0.000245	0.00052	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—NOTCH3—esophageal cancer	0.000244	0.000518	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—GHRL—esophageal cancer	0.000244	0.000518	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—FBXW7—esophageal cancer	0.00024	0.00051	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—TYMP—esophageal cancer	0.000239	0.000508	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—GHRL—esophageal cancer	0.000238	0.000506	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—NOTCH3—esophageal cancer	0.000238	0.000506	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—SMAD4—esophageal cancer	0.000236	0.000501	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—FBXW7—esophageal cancer	0.000235	0.000498	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—NOTCH1—esophageal cancer	0.000233	0.000495	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—CYP26A1—esophageal cancer	0.000232	0.000494	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—ALOX15—esophageal cancer	0.000227	0.000481	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—NOTCH2—esophageal cancer	0.000224	0.000475	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—NOTCH2—esophageal cancer	0.000219	0.000465	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—TPI1—esophageal cancer	0.000216	0.000459	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—GSTO1—esophageal cancer	0.000216	0.000459	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—NOTCH2—esophageal cancer	0.000214	0.000454	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—CREBBP—esophageal cancer	0.000211	0.000449	CbGpPWpGaD
Pindolol—ADRB3—Signaling by GPCR—EGFR—esophageal cancer	0.000208	0.000441	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—ALDOB—esophageal cancer	0.000207	0.00044	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—GAPDH—esophageal cancer	0.000199	0.000424	CbGpPWpGaD
Pindolol—ADRB3—GPCR downstream signaling—PIK3CA—esophageal cancer	0.000198	0.000422	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—TGFBR2—esophageal cancer	0.000198	0.000421	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—CRABP1—esophageal cancer	0.000198	0.00042	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—TGFBR2—esophageal cancer	0.000194	0.000412	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—HIF1A—esophageal cancer	0.000193	0.00041	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—TGFBR2—esophageal cancer	0.00019	0.000403	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—NOS3—esophageal cancer	0.000189	0.000402	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—GNG7—esophageal cancer	0.000188	0.000399	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—SMAD4—esophageal cancer	0.000188	0.000399	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—KDR—esophageal cancer	0.000184	0.000392	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—SMAD4—esophageal cancer	0.000184	0.00039	CbGpPWpGaD
Pindolol—ADRB3—Signaling by GPCR—PIK3CA—esophageal cancer	0.00018	0.000383	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—SMAD4—esophageal cancer	0.00018	0.000381	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—ERBB2—esophageal cancer	0.000177	0.000376	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—ALDH2—esophageal cancer	0.000176	0.000374	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—NOTCH1—esophageal cancer	0.000174	0.000369	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—GSTT1—esophageal cancer	0.000168	0.000356	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—CYP2A6—esophageal cancer	0.000166	0.000352	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—CREBBP—esophageal cancer	0.000158	0.000335	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—ENO1—esophageal cancer	0.000157	0.000334	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—PTGS1—esophageal cancer	0.000157	0.000334	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—CCND1—esophageal cancer	0.000156	0.000332	CbGpPWpGaD
Pindolol—HTR1B—Signaling by GPCR—EGFR—esophageal cancer	0.000155	0.000329	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—PSME1—esophageal cancer	0.000155	0.000329	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—PSME2—esophageal cancer	0.000155	0.000329	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—HIF1A—esophageal cancer	0.000154	0.000326	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—CDKN1A—esophageal cancer	0.000151	0.000321	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—HIF1A—esophageal cancer	0.00015	0.000319	CbGpPWpGaD
Pindolol—HTR1B—GPCR downstream signaling—PIK3CA—esophageal cancer	0.000148	0.000314	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—HIF1A—esophageal cancer	0.000147	0.000312	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—KDR—esophageal cancer	0.000147	0.000312	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—EP300—esophageal cancer	0.000144	0.000306	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—KDR—esophageal cancer	0.000144	0.000305	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—NOS3—esophageal cancer	0.000141	0.0003	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—KDR—esophageal cancer	0.00014	0.000298	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—NOTCH1—esophageal cancer	0.000138	0.000294	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—NOTCH1—esophageal cancer	0.000135	0.000288	CbGpPWpGaD
Pindolol—HTR1B—Signaling by GPCR—PIK3CA—esophageal cancer	0.000134	0.000285	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—CYP1B1—esophageal cancer	0.000134	0.000284	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—NOTCH1—esophageal cancer	0.000132	0.000281	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—ERBB2—esophageal cancer	0.000132	0.00028	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—CYP19A1—esophageal cancer	0.000126	0.000267	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—CREBBP—esophageal cancer	0.000125	0.000267	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—MYC—esophageal cancer	0.000125	0.000266	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—EGFR—esophageal cancer	0.000123	0.000262	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—CREBBP—esophageal cancer	0.000123	0.000261	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—EGFR—esophageal cancer	0.000123	0.000261	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—EGFR—esophageal cancer	0.000121	0.000256	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—CREBBP—esophageal cancer	0.00012	0.000255	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—EGFR—esophageal cancer	0.000118	0.000251	CbGpPWpGaD
Pindolol—ADRB1—GPCR downstream signaling—PIK3CA—esophageal cancer	0.000118	0.00025	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—CCND1—esophageal cancer	0.000117	0.000248	CbGpPWpGaD
Pindolol—ADRB2—GPCR downstream signaling—PIK3CA—esophageal cancer	0.000115	0.000245	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—HMOX1—esophageal cancer	0.000115	0.000243	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—CDKN1A—esophageal cancer	0.000113	0.00024	CbGpPWpGaD
Pindolol—HTR1A—GPCR downstream signaling—PIK3CA—esophageal cancer	0.000113	0.000239	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—NOS3—esophageal cancer	0.000112	0.000239	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—ABCB1—esophageal cancer	0.00011	0.000234	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—NOS3—esophageal cancer	0.00011	0.000233	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—NOS3—esophageal cancer	0.000107	0.000228	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—EP300—esophageal cancer	0.000107	0.000228	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—PIK3CA—esophageal cancer	0.000107	0.000227	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—PIK3CA—esophageal cancer	0.000106	0.000226	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—ERBB2—esophageal cancer	0.000105	0.000223	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—PIK3CA—esophageal cancer	0.000105	0.000222	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—TP53—esophageal cancer	0.000103	0.000219	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—ERBB2—esophageal cancer	0.000103	0.000218	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—PIK3CA—esophageal cancer	0.000102	0.000217	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—ERBB2—esophageal cancer	0.0001	0.000213	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—MYC—esophageal cancer	9.35e-05	0.000199	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—CCND1—esophageal cancer	9.28e-05	0.000197	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—EGFR—esophageal cancer	9.14e-05	0.000194	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—CCND1—esophageal cancer	9.08e-05	0.000193	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—CDKN1A—esophageal cancer	8.98e-05	0.000191	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—CCND1—esophageal cancer	8.88e-05	0.000189	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—CDKN1A—esophageal cancer	8.78e-05	0.000187	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—CDKN1A—esophageal cancer	8.59e-05	0.000182	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—EP300—esophageal cancer	8.54e-05	0.000182	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—EP300—esophageal cancer	8.36e-05	0.000178	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—EP300—esophageal cancer	8.17e-05	0.000174	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—PIK3CA—esophageal cancer	7.94e-05	0.000169	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—TP53—esophageal cancer	7.68e-05	0.000163	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—MYC—esophageal cancer	7.44e-05	0.000158	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—CREBBP—esophageal cancer	7.35e-05	0.000156	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—MYC—esophageal cancer	7.28e-05	0.000155	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—EGFR—esophageal cancer	7.28e-05	0.000155	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—EGFR—esophageal cancer	7.12e-05	0.000151	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—MYC—esophageal cancer	7.12e-05	0.000151	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—EGFR—esophageal cancer	6.97e-05	0.000148	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—NOS3—esophageal cancer	6.58e-05	0.00014	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—PIK3CA—esophageal cancer	6.32e-05	0.000134	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—PIK3CA—esophageal cancer	6.18e-05	0.000131	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—TP53—esophageal cancer	6.11e-05	0.00013	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—PIK3CA—esophageal cancer	6.05e-05	0.000128	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—PTGS2—esophageal cancer	6.02e-05	0.000128	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—TP53—esophageal cancer	5.98e-05	0.000127	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—TP53—esophageal cancer	5.85e-05	0.000124	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—EP300—esophageal cancer	5.01e-05	0.000106	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—PIK3CA—esophageal cancer	3.7e-05	7.87e-05	CbGpPWpGaD
